Brugada syndrome as a potential cardiac risk factor during electroconvulsive therapy (ECT)

World Journal of Biological Psychiatry

Volumn 9, Issue 2, 2008, Pages 150-153

  Luckhaus, Christian ^a   Hennersdorf, Marcus ^a   Bell, Michael ^b   Agelink, Markus W ^c   Zielasek, Jürgen ^a   Cordes, Joachim ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ELISABETH KRANKENHAUS ESSEN   (Germany)

^c Klinikum Herford   (Germany)

Author keywords

Brugada syndrome; Cardiac arrhythmia; ECT; Electroconvulsive therapy; Side effects

Indexed keywords

AMITRIPTYLINE; ATROPINE; CITALOPRAM; CLOZAPINE; DIAZEPAM; FLUPHENAZINE; LAMOTRIGINE; LEVOTHYROXINE; LITHIUM; MELPERONE; METHYLPHENIDATE; PROPOFOL; SUXAMETHONIUM; VALPROIC ACID;

ADULT; ANAMNESIS; ARTICLE; ASYSTOLE; BIPOLAR DISORDER; BRUGADA SYNDROME; CASE REPORT; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; ELECTROCONVULSIVE THERAPY; HOSPITAL ADMISSION; HUMAN; HYPERACTIVITY; LOW DRUG DOSE; MALE; MANIA; RISK FACTOR; STUPOR;

ADULT; BIPOLAR DISORDER; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; ELECTROCONVULSIVE THERAPY; HUMANS; MALE; SEVERITY OF ILLNESS INDEX;

EID: 42449159311     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970701432544     Document Type: Article

References (17)

1. Abrahams, R. (1992) Electroconvulsive Therapy, Oxford University Press, New York
2. Agelink, MM, Zeit, T. and Klieser, E. (1998) Prolonged bradycardia complicates antidepressive treatment with venlafaxine and ECT. Br J Psychiatry, 173, p. 441.
3. Atarashi, H., Ogawa, S. and Harumi, K. (2001) Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese Registry of Brugada Syndrome. Idiopathic Ventricular Fibrillation Investigators. J Am Coll Cardiol, 37, pp. 1916-1920.
4. Bhat, SK, Acosta, D. and Swartz, CM (2002) Postictal asystole during ECT. J ECT, 18, pp. 103-106.
5. Bordachar, P., Reuter, S. and Garrigue, S. (2004) Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur Heart J, 25, pp. 879-884.
6. Brugada, P. and Brugada, J. (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death. A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol, 20, pp. 1391-1396.
7. Burd, J. and Kettl, P. (1998) Incidence of asystole in electroconvulsive therapy in elderly patients. Am J Psychiatry, 6, pp. 203-211.
8. Hase, K., Yoshioka, H., Nakamura, T., Kamei, T., Isse, K. and Nakamura, M. (2005) Asystole during electroconvulsive therapy. Masui, 54, pp. 1268-1272.
9. Hong, K., Brugada, J. and Oliva, A. (2004) Value of electrocardiaographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation, 110, pp. 3023-3027.
10. Junttila, MJ, Raatikainen, MJP, Karjalainen, J., Kauma, H., Kesäniemi, YA and Hurikuri, HV (2004) Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population. Eur Heart J, 25, pp. 874-878.
11. Keller, DI, Carrier, L. and Schwartz, K. (2002) Genetics of familial cardiomyopathies and arrhythmias. Swiss Med Wkly, 132, pp. 401-407.
12. McCall, W. (1996) Asystole in electroconvulsive therapy. Report of four cases. J Clin Psychiatry, 57, pp. 199-203.
13. Merrill, DB, Dec, GW and Goff, DC (2005) Adverse cardiac effects associated with clozapine. J Clin Psychopharmacol, 25, pp. 32-41.
14. Pacher, P. and Kecskemeti, V. (2004) Cardiovascular side effects of the new antidepressants and antipsychotics: New drugs, old concerns?. Curr Pharm Res, 10, pp. 2463-2475.
15. Saint, DA and Tang, Y. (1998) Propofol block of cardiac sodium currents in rat isolated myocardial cells is increased at depolarized resting potentials. Clin Exp Pharmacol Physiol, 25, pp. 336-340.
16. Shiwach, RS, Reid, WH and Carmody, TJ (1998) An analysis of reported deaths following electroconvulsive therapy in Texas, 1993-1998. Psychiatr Serv, 52, pp. 1095-1097.
17. Thamacoody, HK and Thomas, SH (2005) Tricyclic antidepressant poisoning: cardiovascular toxicity. Toxicol Rev, 24, pp. 205-214.